Conference Proceedings

A managed switch program from originator to biosimilar infliximab in inflammatory bowel disease: An opportunity for proactive therapeutic optimization using a treat-to-target approach

P Hilley, R Gilmore, C Li Wai Suen, K Hine, K Boyd, MC Choy, A Srinivasan, P De Cruz

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | WILEY | Published : 2020